Ray Therapeutics Receives $4M in Funding From the California Institute for Regenerative Medicine (CIRM)

– Funding will Advance Development of Ray Therapeutics’ Optogenetics Technology Platform – Company will Advance Ray-001 for the Treatment of Retinitis Pigmentosa SAN DIEGO–(BUSINESS WIRE)– Ray Therapeutics, a biotechnology company developing optogenetic gene therapies for patients with retinal degenerative conditions, announced today that the California Institute for Regenerative Medicine (CIRM) has awarded the company a […]